Dr. Statland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd
Stop 2012
Kansas City, KS 66160Phone+1 913-588-6970Fax+1 913-588-0609
Education & Training
- University of Kansas School of MedicineResidency, Neurology, 2007 - 2010
- University of Kansas School of MedicineResidency, Internal Medicine, 2006 - 2007
- University of Kansas School of MedicineClass of 2005
Certifications & Licensure
- KS State Medical License 2014 - 2025
- MO State Medical License 2022 - 2025
- CO State Medical License 2022 - 2023
- WA State Medical License 2019 - 2023
- NY State Medical License 2010 - 2014
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Rasch-analysis of Clinical Severity in FSHD Start of enrollment: 2016 Mar 01
- Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD Start of enrollment: 2018 Mar 05
- Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis Start of enrollment: 2018 Jun 11
- Join now to see all
Publications & Presentations
PubMed
- 52 citationsEffect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.Michela Guglieri, Kate Bushby, Michael P McDermott, Kimberly A Hart, Rabi Tawil
JAMA. 2022-04-19 - 9 citationsPredictors of functional outcomes in patients with facioscapulohumeral muscular dystrophy.Natalie K. Katz, John Hogan, Ryan Delbango, Colin Cernik, Rabi Tawil
Brain. 2021-09-20 - 75 citationsEffect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 TrialsBas C. Stunnenberg, Joost Raaphorst, Hans Groenewoud, Jeffrey Statland, Robert C. Griggs
JAMA. 2018-12-11
Press Mentions
- Avidity Biosciences Enters into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial UseAugust 16th, 2021
- Muscular Dystrophy Association Virtual Conference to Feature Latest Advances in Neuromuscular Therapy and Clinical CareMarch 8th, 2021
- FSHD Society Is Funding the Expansion of the FSHD Clinical Trial Research NetworkAugust 11th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: